Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid
- 15 May 1994
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 29 (2) , 373-377
- https://doi.org/10.1016/0360-3016(94)90292-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Second-generation 1,2,4-benzotriazine 1,4-di-N-oxide bioreductive anti-tumor agents: Pharmacology and activity in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Hypoxia-selective antitumor agents. 5. Synthesis of water-soluble nitroaniline mustards with selective cytotoxicity for hypoxic mammalian cellsJournal of Medicinal Chemistry, 1992
- Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acidsJournal of Medicinal Chemistry, 1991
- Induction of Hypoxia in the KHT Sarcoma by Tumour Necrosis Factor and Flavone Acetic AcidInternational Journal of Radiation Biology, 1991
- Induction of Tumour Hypoxia by FAA and TNF: Interaction with Bioreductive DrugsInternational Journal of Radiation Biology, 1991
- Vascular collapse after flavone acetic acid: A possible mechanism of its anti-tumour actionEuropean Journal of Cancer and Clinical Oncology, 1989
- Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumoursEuropean Journal of Cancer and Clinical Oncology, 1987